Selected publications on clinical trials
Other topics
Sort by (choose one or two options): Authors - Title - (Year) - Journal - PDF available - Internal PID - Database PK
A balanced carbohydrate: Protein diet in the management of Parkinson's disease.
Neurology, 41:1295-1297, 1991.
D-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression.
Obstet. & Gynecol., 76(2):296-391, 1990.
Plasma amino acid levels in obesity: Effects of insulin resistance.
Amino Acids in Health and Diseases: New Perspectives (S. Kaufman, ed.) Alan R. Liss, Inc., New York, pp.369-382, 1987.
Plasma amino acids and insulin levels in obesity: Response to carbohydrate intake and tryptophan supplements.
Metabolism, 37(7):672-676, 1988.
Plasma amino acid concentrations in healthy elderly men and women.
Am. J. Clin. Nutr., 53:1249-1252, 1991.
Differential effects of insulin resistance on leucine and glucose kinetics in obesity.
Metabolism, 40(1):51-58, 1991.
Caffeine alters plasma adenosine levels.
Nature, 389:136, 1997.
Endogenous adenosine and hemorrhagic shock: Effects of caffeine administration or caffeine withdrawal.
Proc. Natl. Acad. Sci., 85:4483-4485, 1988.
Decreased plasma choline concentrations in marathon runners.
New Eng. J. Med., 315:892, 1986.
Effects of illumination on human nocturnal serum melatonin levels and performance.
Physiol. & Beh., 53:153-160, 1993.
Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance.
Proc. Natl. Acad. Sci., 91:1824-1828, 1994.
A1 and A2-selective adenosine antagonists: In Vivo characterization of cardiovascular effects.
J. Pharmacol. Exp. Ther., 242(3):882-887, 1987.
Adenosine affects sympathetic neurotransmission at multiple sites in vivo.
J. Pharmacol. Exp. Ther., 236(2):350-355, 1986.
Diurnal variations in plasma neutral amino acid concentrations among patients with cirrhosis: Effect of dietary protein.
Am. J. Clin. Nutr., 32:1923-1933, 1979.
Diurnal variations in plasma concentrations of tryptophan, tyrosine, and other neutral amino acids: Effect of dietary protein intake.
Am. J. Clin. Nutr., 32:1912-1922, 1979.
Tyrosine for the treatment of depression.
Am. J. Psychiatry, 137(5):622-623, 1980.
Changes in brain levels of acidic, basic, and neutral amino acids after consumption of single meals containing proportions of protein.
J. Neurochem., 41(4):1016-1021, 1983.
Lecithin can suppress tardive dyskinesia.
New Eng. J. Med., 298:1029-1030, 1978.
Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease.
Life Sci., 30:827-832, 1982.
L-threonine in the treatment of spasticity.
Clin. Neuropharm., 14(5):403-412, 1991.
Oral choline administration to patients with Huntington's disease.
In: Advances in Neurology, A. Barbeau, N. Wexler, and T.N. Chase, eds.) Raven Press, New York, Vol. 23:765-776, 1979.
Tryptophan administration may enhance weight loss by some moderately obese patients on a protein-sparing modified fast (PSMF) diet.
Int. J. Eating Disorders, 4:281-292, 1985.
Effects of COMT inhibitors on striatal dopamine metabolism: A microdialysis study.
Brain Res., 597:241-249, 1992.
The effects of dietary neurotransmitter precursors on human behavior.
Am. J. Clin. Nutri., 42:366-370, 1985.
Effects of melatonin on human mood and performance.
Brain Res., 323:201-207, 1984.
The effects of caffeine and aspirin onmood and performance.
J. Clin. Psychopharm., 75(5):315-320, 1987.
Daily rhythm in human urinary melatonin.
Science, 187:169-171, 1975.
Diurnal variations in plasma concentrations of basic and neutral amino acids and in red cell concentrations of aspartate and glutamate: effects of dietary protein intake.
Am. J. Clin. Nutr., 39:722-729, 1984.
Phentermine and other monoamine-oxidase inhibitors may increase plasma serotonin when given with fenfluramines.
The Lancet, 353(9146):38, 1999.
Effect of various oral glucose doses on plasma neutral amino acid levels.
Metabolism, 31(9):937-943, 1982.
Blood-brain barrier transport of caffeine: Dose-related restriction of adenine transport.
Life Sci., 31:2079-2715, 1982.
Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus.
Proc. Natl. Acad. Sci., 79:5406-5410, 1982.
Evidence for a membrane defect in Alzheimer disease brain.
Proc. Natl. Acad. Sci., 89:1671-1675, 1992.
The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome.
Obstet. Gynecol., 86(4):520-528, 1995.
Efficacy of a medical food in mild Alzheimer's disease: a randomized controlled trial.
Alzheimer's and Dementia, 6:1-10, 2010.
Neural control of dieting.
Nature, 380:488, 1996.
Citicoline improves verbal memory in aging.
Arch. Neurol., 53:441-448, 1996.
Neuroendocrine effects of caffeine in normal subjects.
Clin. Pharm. Therap., 36(3):402-407, 1984.
Increased TRH content of the basal ganglia in Huntington's disease.
New Eng. J. Med., 303:1235-1236, 1980.
Weight gain and withdrawal symptoms after smoking cessation: A preventive intervention using d-fenfluramine.
Health Psychol., 10(3):216-223, 1991.
Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation.
Am. J. Clin. Nutr., 62:1181-1187, 1995.
Environmental conditions influence hippocampal-dependent behaviors and brain levels of amyloid precursor protein.
Eur. J. Neurosci., 16:2405-2415, 2002.
Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors.
Biochem. Pharm., 59:1611-1621, 2000.
Adenosine strongly potentiates pressor responses to nicotine in rats.
Proc. Natl. Acad. Sci., 81:5599-5603, 1984.
Chronic caffeine consumption potentiates the hypotensive action of circulating adenosine.
Life Sci., 32:1151-1158, 1983.
Effect of nutrient intake on premenstrual depression.
Am. J. Obstet. Gynecol., 161(5):1228-1234, 1989.
The effect of a novel dietary intervention on weight loss in psychotropic drug-induced obesity.
Psychopharm. Bull., 36(3):55-59, 2002.
D-fenfluramine selectively suppresses carbohydrate snacking by obese subjects.
Int. J. Eating Disorders, 4(1):89-99, 1985.
Personalized medicine strategies for managing patients with Parkinsonism and cognitive deficits.
Metabolism Clinical and Experimental, 62:S27-S29, 2013.
Depression can beget obesity can beget depression.
J. of Clin Psychiatry, 76:12:e1619-e1621, 2015.
Pineal organ.
In: Pediatrics. (A.M. Rudolph, ed.) Appleton-Century-Crofts, New York, pp.1693-1694, 1977.
Genes, stress, and depression.
Metabolism, 54(1):16-19, 2005.
Narcolepsy and the hypocretins.
Metabolism:Clinical and Expermental, 55(Suppl 2):S36-S39, 2006.
Fibromyalgia and the complex regional pain syndrome: Similarities in pathophysiology and treatment.
Metabolism Clinical and Experimental, 59(Suppl 1):S37-S40, 2010.
Facilitation of levodopa-induced dyskinesias by dietary carbohydrates.
New Eng. J. Med., 319:1288-1289, 1988.
Effect of oral CDP-choline on plasma choline and uridine levels in humans.
Biochem. Pharm., 60:989-992, 2000.
Effects of normal meals rich in carbohydrates or proteins on the plasma tryptophan ratio.
Am. J. Clin. Nutrition, 77:128-132, 2003.
Effects of normal meals rich in carbohydrates or proteins on the plasma tryptophan ratio.
Am. J. Clin. Nutrition, 77:128-132, 2003.
Control of brain monoamine synthesis by diet and plasma amino acids.
Am. J. Clin. Nutr., 28:638-647, 1975.
Carbohydrates and depression.
Sci. Am., 260(1):68-75, 1989.
Monoamine neurotransmitters and the pathophysiology of stroke and central nervous system trauma.
J. Neurosurgery, 40(1):34-36, 1974.
Sexual maturation in contemporary American girls.
Amer. J. Obstet. Gynecol., 108(5):833-846, 1970.
Blindness: Its relation to age of menarche.
Science, 144(3622):1154-1155, 1964.
Age at menarche: Genetic and environmental influences.
New Eng. J. Med., 280:868-875, 1969.
Blindness and menarche.
Obstet. Gynecol., 33(5):603-608, 1969.
Elevated choline concentration in neonatal plasma.
Life Sci., 26:1827-1831, 1980.
Reduction in brain dopamine following experimental cerebral ischemia.
Nature, 247(5439):283-284, 1974.
Edogenous melatonin levels and the fate of exogenous melatonin: Age effects.
J. Gerontology, 53A(4):B293-B298, 1998.
Sleep-inducing effects of low doses of melatonin ingested in the evening.
Clin. Pharm. Therap., 57(5):552-558, 1995.
Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans.
Sleep, 19(5):423-431, 1996.
Melatonin treatment for age-related insomnia.
J. Clin. Endocrin. Metab., 86(10):4727-4730, 2001.
Effects of a low dose of melatonin on sleep in children with Angelman syndrome.
J. Ped. Endocrin. Metab., 12:57-67, 1999.
Efficacy of melatonin as a sleep-promoting agent.
J. Biol. Rhythms, 12(6):644-650, 1997.